Aurinia Pharmaceuticals Inc. (AUPH) Cash Flow Statement
Aurinia Pharmaceuticals Inc. (AUPH) generated $175.2M of operating cash flow over the twelve months to 2026-06-30, spent $176000 on capital expenditure and had free cash flow of $175.1M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AUPHAurinia Pharmaceuticals Inc.Follow AUPH — free
—
Price chart with a free account
- Market cap
- 2.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 4 days
| Line | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | — | — | -69.9 | -157.7 | -79.5 | -33.5 | 44.4 | 135.7 | 175.2 | |
| Capital expenditure | 0.0 | 0.0 | 0.1 | 5.7 | 0.3 | 0.3 | 0.7 | 0.3 | 0.3 | -0.2 | |
| Free cash flow | — | — | — | -75.5 | -158.0 | -79.8 | -34.2 | 44.1 | 135.4 | 175.1 | |
| Share repurchases | — | — | — | — | — | — | 0.0 | 40.2 | 98.2 | — | |
| Stock-based compensation | — | — | — | 17.5 | 31.2 | 32.3 | 45.3 | 31.6 | 14.7 | — |
USD millions · SEC XBRL
Aurinia Pharmaceuticals Inc. — questions
- What is Aurinia Pharmaceuticals Inc.'s operating cash flow?
- $175.2M over the twelve months to 2026-06-30.
- How much does Aurinia Pharmaceuticals Inc. spend on capital expenditure?
- $176000 over the twelve months to 2026-06-30.
- What is Aurinia Pharmaceuticals Inc.'s free cash flow?
- $175.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Aurinia Pharmaceuticals Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.